3.480USD-2.79%Mkt Cap: 7.46M $P/E: —2d ago
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in …
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap7.46M $
Enterprise Value-798.68K $
Revenue (TTM)405.00K $
Gross Profit405.00K $
Net Income (TTM)-9.83M $
Revenue/Share0.4920 USD
Last Price3.480 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-12.78
PEG—
EV/EBITDA0.08
EV/Revenue-1.97
P/S18.25
P/B0.81
EPS (TTM)-10.75
EPS (Forward)-0.27
52W Range
2.5608% of range13.60
52W High13.60 USD
52W Low2.560 USD
Profitability
Gross Margin100.00%
Oper. Margin-2488.67%
EBITDA Margin0.00%
Profit Margin-2426.67%
ROE-175.75%
ROA-103.30%
Growth
Revenue Growth-43.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.95M $
CapEx (TTM)2.00K $
FCF Margin-1231.05%
FCF Yield-66.87%
Net Debt-8.47M $
Net Debt/EBITDA0.85
Balance Sheet
Debt/Equity0.01
Current Ratio3.46
Quick Ratio3.13
Book Value/Sh4.272 USD
Cash/Share3.986 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateMay 10, 2019
Splits
Last Split1:20
Split DateJan 5, 2026
Analyst Consensus
Rating—
Target (Mean)8.000 USD
Upside (mean)+129.9%
Target Range8.000 USD – 8.000 USD
# Analysts1
Ownership
Shares Out.2.14M
Float2.14M
Insiders0.00%
Institutions2.44%
Short Interest
Short Ratio0.0d
Short % Float3.10%
Short % Out.3.08%
Shares Short66.09K
Short (prev mo.)321.50K
Technical
SMA 503.232 (+7.7%)
SMA 2004.222 (-17.6%)
Beta-0.04
S&P 52W Chg20.80%
Avg Vol (30d)92.77K
Avg Vol (10d)44.71K
Technical Indicators
RSI (14)55.0
MACD0.0561
MACD Signal0.0300
MACD Hist.+0.0261
BB Upper3.589 USD
BB Middle3.305 USD
BB Lower3.022 USD
BB Width17.17%
ATR (14)0.2156 USD
Vol Ratio (20d)0.36x